Teens say they are turning to AI for advice, friendship and 'to get out of thinking'
The 15-year-old asks ChatGPT for guidance on back-to-school shopping, makeup colors, low-calorie choices at Smoothie King, plus ideas for her Sweet 16 and her younger sister's birthday party.
The sophomore honors student makes a point not to have chatbots do her homework and tries to limit her interactions to mundane questions. But in interviews with The Associated Press and a new study, teenagers say they are increasingly interacting with AI as if it were a companion, capable of providing advice and friendship.
'Everyone uses AI for everything now. It's really taking over,' said Chege, who wonders how artificial intelligence will affect her generation. 'I think kids use AI to get out of thinking.'
For the past couple of years, concerns about cheating at school have dominated the conversation around kids and AI. But artificial intelligence is playing a much larger role in many of their lives. AI, teens say, has become a go-to source for personal advice, emotional support, everyday decision-making and problem-solving.
'AI is always available. It never gets bored with you'
More than 70% of teens have used AI companions and half use them regularly, according to a new study from Common Sense Media, a group that studies and advocates for using screens and digital media sensibly.
The study defines AI companions as platforms designed to serve as 'digital friends,' like Character.AI or Replika, which can be customized with specific traits or personalities and can offer emotional support, companionship and conversations that can feel human-like. But popular sites like ChatGPT and Claude, which mainly answer questions, are being used in the same way, the researchers say.
As the technology rapidly gets more sophisticated, teenagers and experts worry about AI's potential to redefine human relationships and exacerbate crises of loneliness and youth mental health.
'AI is always available. It never gets bored with you. It's never judgmental,' says Ganesh Nair, an 18-year-old in Arkansas. 'When you're talking to AI, you are always right. You're always interesting. You are always emotionally justified.'
All that used to be appealing, but as Nair heads to college this fall, he wants to step back from using AI. Nair got spooked after a high school friend who relied on an 'AI companion' for heart-to-heart conversations with his girlfriend later had the chatbot write the breakup text ending his two-year relationship.
'That felt a little bit dystopian, that a computer generated the end to a real relationship,' said Nair. 'It's almost like we are allowing computers to replace our relationships with people.'
How many teens are using AI? New study stuns researchers
In the Common Sense Media survey, 31% of teens said their conversations with AI companions were 'as satisfying or more satisfying' than talking with real friends. Even though half of teens said they distrust AI's advice, 33% had discussed serious or important issues with AI instead of real people.
Those findings are worrisome, says Michael Robb, the study's lead author and head researcher at Common Sense, and should send a warning to parents, teachers and policymakers. The now-booming and largely unregulated AI industry is becoming as integrated with adolescence as smartphones and social media are.
'It's eye-opening,' said Robb. 'When we set out to do this survey, we had no understanding of how many kids are actually using AI companions.' The study polled more than 1,000 teens nationwide in April and May.
Adolescence is a critical time for developing identity, social skills and independence, Robb said, and AI companions should complement — not replace — real-world interactions.
'If teens are developing social skills on AI platforms where they are constantly being validated, not being challenged, not learning to read social cues or understand somebody else's perspective, they are not going to be adequately prepared in the real world,' he said.
The nonprofit analyzed several popular AI companions in a ' risk assessment,' finding ineffective age restrictions and that the platforms can produce sexual material, give dangerous advice and offer harmful content. The group recommends that minors not use AI companions.
A concerning trend to teens and adults alike
Researchers and educators worry about the cognitive costs for youth who rely heavily on AI, especially in their creativity, critical thinking and social skills. The potential dangers of children forming relationships with chatbots gained national attention last year when a 14-year-old Florida boy died by suicide after developing an emotional attachment to a Character.AI chatbot.
'Parents really have no idea this is happening,' said Eva Telzer, a psychology and neuroscience professor at the University of North Carolina at Chapel Hill. 'All of us are struck by how quickly this blew up.' Telzer is leading multiple studies on youth and AI, a new research area with limited data.
Telzer's research has found that children as young as 8 are using generative AI and also found that teens are using AI to explore their sexuality and for companionship. In focus groups, Telzer found that one of the top apps teens frequent is SpicyChat AI, a free role-playing app intended for adults.
Many teens also say they use chatbots to write emails or messages to strike the right tone in sensitive situations.
'One of the concerns that comes up is that they no longer have trust in themselves to make a decision,' said Telzer. 'They need feedback from AI before feeling like they can check off the box that an idea is OK or not.'
Arkansas teen Bruce Perry, 17, says he relates to that and relies on AI tools to craft outlines and proofread essays for his English class.
'If you tell me to plan out an essay, I would think of going to ChatGPT before getting out a pencil,' Perry said. He uses AI daily and has asked chatbots for advice in social situations, to help him decide what to wear and to write emails to teachers, saying AI articulates his thoughts faster.
Perry says he feels fortunate that AI companions were not around when he was younger.
'I'm worried that kids could get lost in this,' Perry said. 'I could see a kid that grows up with AI not seeing a reason to go to the park or try to make a friend.'
Other teens agree, saying the issues with AI and its effect on children's mental health are different from those of social media.
'Social media complemented the need people have to be seen, to be known, to meet new people,' Nair said. 'I think AI complements another need that runs a lot deeper — our need for attachment and our need to feel emotions. It feeds off of that.'
'It's the new addiction,' Nair added. 'That's how I see it.'
___
The Associated Press' education coverage receives financial support from multiple private foundations. AP is solely responsible for all content. Find AP's standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Waystar to Acquire Iodine Software, Accelerating the AI-Powered Transformation of Healthcare Payments
Extends Waystar's AI leadership into clinical intelligence software, unlocking greater value for clients and shareholders Highly recurring subscription-based business projected to be accretive to Waystar's financial profile Expected to expand Waystar's total addressable market by more than 15% Conference call to be held Wednesday, July 23, 2025, at 5:30 p.m. ET LEHI, Utah and LOUISVILLE, Ky., and AUSTIN, Texas, July 23, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced a definitive agreement to acquire 100% of Iodine Software ("Iodine") from shareholders led by Advent International, a leading global private equity investor, for a total enterprise value of $1.25 billion. The proposed transaction is expected to accelerate Waystar's ability to transform healthcare payments through its leading cloud-based software platform, empowering more than one million providers with advanced AI capabilities to prevent denials, reduce manual work, and improve financial performance. Building on Waystar's track record of successful M&A execution and synergy realization, Waystar expects the acquisition of Iodine to be immediately accretive to gross margin and adjusted EBITDA margin, and accretive to revenue growth and non-GAAP net income per diluted share in 2027. Iodine is trusted by many of the nation's premier health systems for its AI-powered clinical intelligence software. Up to 60 million claims are denied each year due to administrative errors in the critical stage between care delivery and submission, costing providers billions in lost revenue. This highlights the essential role of accurate clinical documentation and coding in preventing revenue leakage and underpayments. Together, Waystar and Iodine will be better positioned to help decrease the estimated $440 billion in annual administrative costs1 burdening providers. Waystar brings a decade-long track record of applying AI pervasively across its software platform to simplify healthcare payments. Iodine extends that leadership into clinical intelligence software, leveraging proprietary AI models trained on one of the industry's largest clinical datasets, representing more than a third of all U.S. inpatient discharges. "Our mission is to simplify healthcare payments by eradicating unnecessary denied claims, automating manual work, and increasing transparency for providers and patients," said Matt Hawkins, Chief Executive Officer of Waystar. "We are committed to transforming healthcare through harnessing the power of AI to tackle the most critical challenges in healthcare payments. Welcoming Iodine's talented team and clinical intelligence platform to Waystar is a terrific next step in achieving our mission." "We are proud to have built a market-leading AI software company in partnership with Advent, Bain Capital Ventures, and Silversmith Capital Partners, and are thrilled to join Waystar, an organization that shares our deep commitment to modernizing the revenue cycle for providers," said William Chan, Co-Founder and Chief Executive Officer of Iodine Software. "From day one, our focus has been helping hospitals and health systems capture the full value of care through transformational AI. As part of Waystar, we are excited to accelerate that mission and amplify the value delivered to healthcare providers." "Our success has been driven by strong partnerships, continuous innovation, and meaningful outcomes," added Mike Kadyan, Co-Founder and Chairman of Iodine Software. "We look forward to delivering even greater outcomes for providers as part of Waystar's market-leading platform." "It has been a privilege to partner alongside the Iodine team as they have built a category-defining AI-powered revenue cycle platform consistently delivering exceptional ROI to its clients," said Lauren Young and Carmine Petrone, Managing Directors at Advent. "We are excited to build on that foundation together with Waystar to drive even greater impact across healthcare, empowering organizations to optimize their financial performance." Strategic and Financial Benefits Unlocks transformational outcomes across the revenue cycle: Waystar expects to unlock new automation throughout its platform, leveraging Iodine's industry-leading AI capabilities in clinical documentation integrity, utilization management, and prebill revenue leakage identification to further streamline cumbersome tasks for providers. The addition of these solutions is expected to expand Waystar's total addressable market by more than 15%. Accelerates AI innovation with clinical intelligence: Integrating Iodine's unique clinical data assets with Waystar's expansive data network is expected to enhance the impact and reach of Waystar AltitudeAI™. Waystar expects to create opportunities that quickly expand GenAI applications in prior authorizations, claims management and processing, denial prevention, and appeals. Iodine's proprietary clinical AI engine, IodineIQ, continuously trains on millions of patient encounters and billions of clinical data points to deliver relevant insights. Deepens relationships with premier health systems: Iodine brings strong adoption and credibility among leading hospitals and health systems. Iodine's footprint is expected to expand Waystar's scale and deepen relationships with premier providers. The combined company is expected to serve 17 of the 20 U.S. News Best Hospitals. Strengthens Waystar's financial profile: Waystar will benefit from Iodine's fully subscription-based revenue model as well as significant cross-sell potential to both companies' client bases. In addition, Waystar has identified more than $15 million in run-rate cost synergies, to be realized within the first 18-24 months following closing. Transaction DetailsThe transaction will be funded with a 50/50 mix of cash and stock consideration. Upon closing of the transaction, current Waystar shareholders will own approximately 92% of the combined company on a fully diluted, pro forma basis and Iodine equity holders will own approximately 8%. Advent, Iodine's largest shareholder, is expected to only receive Waystar shares in connection with the transaction and will agree to be locked up for 18 months after closing. Following the transaction, Waystar expects to maintain a strong balance sheet with an estimated adjusted net leverage ratio at transaction close of approximately 3.5x. The transaction is anticipated to close by year-end 2025, subject to customary closing conditions and applicable regulatory approvals. Preliminary Second Quarter 2025 ResultsWaystar expects second quarter 2025 revenue to be approximately $271 million, representing approximately 15% year-over-year growth. The foregoing estimates are preliminary and unaudited and based on management's initial analysis of operations for the quarter. Waystar looks forward to sharing additional information regarding the company's second quarter 2025 results as previously scheduled on July 30, 2025. AdvisorsBarclays is serving as exclusive financial advisor, and Simpson Thacher & Bartlett LLP is serving as legal advisor to Waystar. J.P. Morgan Securities is serving as exclusive financial advisor, and Weil, Gotshal & Manges LLP and Queen Saenz + Schultz PLLC are serving as legal advisors to Iodine. Conference CallWaystar will discuss the transaction on a conference call today, Wednesday, July 23, 2025, at 5:30 p.m. Eastern Time. The conference call can be accessed by dialing (800) 715-9871 from the United States and Canada or (646) 307-1963 internationally and using conference code 8810133. A live audio webcast of the conference call will be available on Waystar's investor relations website at Following the call, an audio replay will be archived on the site. About WaystarWaystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at About Iodine Software Iodine Software is the leader in AI-powered clinical intelligence, built to eliminate revenue leakage, lower administrative burden, and ensure accurate reimbursement. Trusted by more than 1,000 hospitals and health systems, Iodine delivers real-time insight and automation across the mid-revenue cycle: connecting clinical documentation, utilization management, and prebill workflows from admission through claim submission. For over a decade, health systems have trusted Iodine to apply the right AI – from machine learning, deep learning, large language models, GenAI, to Agentic AI – to the right use case, consistently delivering reliable, high-impact financial results. At the core of the platform is IodineIQ, our proprietary Clinical Reasoning Knowledge Engine, featuring a robust clinical condition library and a dataset of millions of patient encounters and billions of clinical data points. IodineIQ mirrors clinical reasoning to surface opportunities, predict outcomes, and guide decisions; ensuring the patient's clinical picture is fully and accurately reflected in status, documentation, and final codes. Discover more at About AdventAdvent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. With 16 offices across five continents, we oversee more than USD $94 billion in assets under management* and have made over 430 investments across 44 countries. Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. This approach is bolstered by our deep sub-sector knowledge, which informs every aspect of our investment strategy, from sourcing opportunities to working in partnership with management to execute value creation plans. We bring hands-on operational expertise to enhance and accelerate businesses. As one of the largest privately-owned partnerships, our 660+ colleagues leverage the full ecosystem of Advent's global resources, including our Portfolio Support Group, insights provided by industry expert Operating Partners and Operations Advisors, as well as bespoke tools to support and guide our portfolio companies as they seek to achieve their strategic goals. To learn more, visit our website or connect with us on LinkedIn. *Assets under management (AUM) as of March 31, 2025. AUM includes assets attributable to Advent advisory clients as well as employee and third-party co-investment vehicles. Forward-Looking StatementsThis press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, statements regarding Waystar's expectations relating to future operating results and financial position, including full year 2025, and future periods; anticipated future investments; our industry, business strategy, goals, and deployment of artificial intelligence in our solutions, our market position, offerings, future operations, margins, and profitability. Forward-looking statements include all statements that are not historical facts. These statements may include words such as "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," "outlook," the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release, including any discussion of our guidance for full fiscal year 2025. The forward-looking statements contained in this press release are based on management's current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our operation in a highly competitive industry; our ability to retain our existing clients and attract new clients; our ability to successfully execute on our business strategies in order to grow; our ability to accurately assess the risks related to acquisitions and successfully integrate acquired businesses (including our proposed acquisition of Iodine); our ability to establish and maintain strategic relationships; the growth and success of our clients and overall healthcare transaction volumes; consolidation in the healthcare industry; our selling cycle of variable length to secure new client agreements; our implementation cycle that is dependent on our clients' timing and resources; our dependence on our senior management team and certain key employees, and our ability to attract and retain highly skilled employees; the accuracy of the estimates and assumptions we use to determine the size of our total addressable market; our ability to develop and market new solutions, or enhance our existing solutions, to respond to technological changes, or evolving industry standards; the interoperability, connectivity, and integration of our solutions with our clients' and their vendors' networks and infrastructures; the performance and reliability of internet, mobile, and other infrastructure; the consequences if we cannot obtain, process, use, disclose, or distribute the highly regulated data we require to provide our solutions; our reliance on certain third-party vendors and providers; any errors or malfunctions in our products and solutions; failure by our clients to obtain proper permissions or provide us with accurate and appropriate information; the potential for embezzlement, identity theft, or other similar illegal behavior by our employees or vendors, and a failure of our employees or vendors to observe quality standards or adhere to environmental, social, and governance standards; our compliance with the applicable rules of the National Automated Clearing House Association and the applicable requirements of card networks; increases in card network fees and other changes to fee arrangements; the effect of payer and provider conduct which we cannot control; privacy concerns and security breaches or incidents relating to our platform; the complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity; our ability to adequately protect and enforce our intellectual property rights; our ability to use or license data and integrate third-party technologies; our use of "open source" software; legal proceedings initiated by third parties alleging that we are infringing or otherwise violating their intellectual property rights; claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; health care laws and data privacy and security laws and regulations governing our processing of personal information; reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; consumer protection laws and regulations; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws and regulations; existing laws that regulate our ability to engage in certain marketing activities; our full compliance with website accessibility standards; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; limitations on our ability to use our net operating losses to offset future taxable income ; losses due to asset impairment charges; restrictive covenants in the agreements governing our credit facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; our history of net losses and our ability to achieve or maintain profitability; actions of certain of our significant investors, who may have different interests than the interests of other holders of our securities; and each of the other factors discussed under the heading of "Risk Factors" in the Company's 10-K filed with the Securities and Exchange Commission (the "SEC") on February 18, 2025, and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws. Waystar Media ContactKristin Daniel Yunger / Nick Capuano / Mark FallatiKekst CNCkekst-waystar@ Waystar Investor Contactinvestors@ Iodine Software Media ContactMichelle Whitemjwhite@ Isabella MorrealeSolCommsisabella@ 1 CAQH Index Report 2024 View original content to download multimedia: SOURCE Waystar
Yahoo
27 minutes ago
- Yahoo
Apple beats US appeal claiming it shortchanged customers on iCloud storage
By Jonathan Stempel (Reuters) -A U.S. federal appeals court on Wednesday rejected claims by Apple customers that the iPhone maker gave them less iCloud data storage than they paid for when upgrading. In a 3-0 decision, the 9th U.S. Circuit Court of Appeals in San Francisco said reasonable consumers in the proposed class action would not have been misled by Apple's promises about storage capacity in its iCloud+ plans. The plaintiff Lisa Bodenburg said she paid $2.99 a month for 200 GB of storage, believing Apple would add it to the 5 GB that all iCloud customers receive, and was shortchanged because Apple gave her only 200 GB of total storage, not 205 GB. Circuit Judge Milan Smith, however said Bodenburg "received exactly what Apple promised her" when the Cupertino, California-based company offered "incremental" or "supplemental" storage, on top of the 5 GB she got for free. He cited dismissals of other cases based on "unreasonable assumptions," including that Diet Dr. Pepper would aid in weight loss, and the net weight on a lip balm label failed to reveal that the dispenser's design left some balm inaccessible. "Apple's statements are not false and deceptive merely because [they] may be unreasonably misunderstood by an insignificant and unrepresentative segment of consumers," Smith wrote. Lawyers for Bodenburg did not immediately respond to requests for comment. The decision upheld a May 2024 dismissal by U.S. District Judge Trina Thompson in San Francisco. The case is Bodenburg v Apple Inc, 9th U.S. Circuit Court of Appeals, No. 24-3335.
Yahoo
27 minutes ago
- Yahoo
Google beats on Q2 earnings, raises capex expeditures
Google parent Alphabet (GOOG, GOOGL) reported its second quarter earnings after the bell on Wednesday, beating expectations on the top and bottom lines on the strength of its advertising and cloud businesses. But the company said capital expenditures will climb to $85 billion. Google previously projected $75 billion. "AI is positively impacting every part of the business, driving strong momentum," CEO Sundar Pichai said in a statement. "Search delivered double-digit revenue growth, and our new features, like AI Overviews and AI Mode, are performing well. We continue to see strong performance in YouTube as well as subscriptions offerings. And Cloud had strong growth in revenues, backlog and profitability. Its annual revenue run-rate is now more than $50 billion.' For the quarter, Google saw adjusted earnings per share (EPS) of $2.31 on revenue excluding traffic acquisition costs (TAC) of $81.2 billion. Analysts were anticipating Adj. EPS of $2.17 on revenue ex-TAC of $79.6 billion. The company posted revenue of $71.3 billion during the same period last year. Advertising revenue came in at $71.3 billion versus expectations of $69.6 billion. Search revenue topped out at $54.1 billion versus an anticipated $52.7 billion. YouTube ad revenue was $9.8 billion versus expectations of $9.5 billion. Google Cloud Platform revenue hit $13.6 billion. Analysts were looking for $13.1 billion. Read more: Live coverage of corporate earnings Google, like its other Big Tech peers, continues to splash huge amounts of cash on its AI buildout. This year, the company is expected to drop $75 billion expanding its AI capabilities, including on massive data centers running on both its own home-grown chips and Nvidia's processors. Google is also facing potentially devastating consequences from a judge's decision that held it liable for antitrust violations in search. Judge Amit Mehta of the US District Court for the District of Columbia is expected to issue a ruling on "remedies" that follows the Justice Department's victory against the company sometime next month. Judge Mehta held that Google violated antitrust law by boxing out rivals in the online search engine and online search text markets. To restore competition, he could order Google to refrain from longstanding exclusivity deals with the likes of Apple (AAPL) that set Google Search as the default option on the company's smartphones. Mehta could also force Google to sell off its Chrome browser, the most popular web browser in the world. That would put a dent in Google's all-important search business, a dangerous proposition for the company. Email Daniel Howley at dhowley@ Follow him on X/Twitter at @DanielHowley. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data